Vikas S Ostwal

32PUBLICATIONS
105CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Apr 07, 2026
Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer.

Shraddha Patkar, Tanvi M Shah, Mufaddal Kazi

|Mar 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial.

Vikas Ostwal, Manali Parulekar, Deepali Naughane

|Jan 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Vanita Noronha, Vijay Patil, Nandini Menon

|Dec 31, 2025
A Rare Case of Collision Tumor at the Periampullary Region.

Kshitija Kale, Vikram Chaudhari, Vikas Ostwal

|Dec 22, 2025
Real-World Data on the Practice of Chemoradiation with Select Cohort Consolidation Chemotherapy in High-Risk Locally Advanced Rectal Cancers (SOLAR study).

Mounika Yallala, Rahul Krishnatry, Anjali Shah

|Dec 22, 2025
TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers - A Single Institution Retrospective Analysis.

Ritam Joarder, Dhwani Patel, Atul Tiwari

Pageof 6

Frequent Collaborators

15 joint publications

Prabhat Ghanshyam Bhargava

12 joint publications

Anant Ramaswamy

5 joint publications

Sujay Srinivas

4 joint publications

Akhil Kapoor